Clinical Trials · NCT06041217
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 242
- Start date
- Sep 2023
- Locations
- 21 sites, China, Taiwan
- Primary endpoint
- Change in Body Weight (%)